Literature DB >> 12454461

Structure of human carbonmonoxyhemoglobin at 2.16 A: a snapshot of the allosteric transition.

Martin K Safo1, James C Burnett, Faik N Musayev, Samuel Nokuri, Donald J Abraham.   

Abstract

A 2.16 A resolution structure of high-salt human carbonmonoxyhemoglobin crystallized at pH 6.4 is reported. The quaternary structure is similar to that of 'classic' R-state hemoglobin; however, subtle but significant tertiary structural changes are observed at the alpha(1)beta(2) and symmetrically equivalent alpha(2)beta(1) interfaces--these are the key subunit interfaces that govern the allosteric transition between the R and T states. Specifically, the movement and weakening of two important hydrogen bonds that are diagnostic for R-state structures, beta(2)His97-alpha(1)Thr38 and beta(2)Arg40-alpha(1)Thr41, have been observed. In addition, a phosphate molecule bound between the two beta-subunits (at the entrance to the central water cavity) has been identified and electron density indicates that this molecule occupies two alternate positions that are related by the dyad axis. Both positions superimpose on the 2,3-diphosphoglycerate binding site. One phosphate conformer interacts with beta(2)Asn139, beta(1)His143 and beta(1)His146, while the second interacts with symmetry-related counterparts (beta(1)Asn139, beta(2)His143 and beta(2)His146).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454461     DOI: 10.1107/s0907444902015809

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  10 in total

1.  Structure of human R-state aquomethemoglobin at 2.0 Å resolution.

Authors:  Jun Yi; Leonard M Thomas; George B Richter-Addo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-05-24

2.  Liquid-liquid phase separation in hemoglobins: distinct aggregation mechanisms of the beta6 mutants.

Authors:  Qiuying Chen; Peter G Vekilov; Ronald L Nagel; Rhoda Elison Hirsch
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

3.  Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation.

Authors:  Mohini S Ghatge; Mostafa H Ahmed; Abdel Sattar M Omar; Piyusha P Pagare; Susan Rosef; Glen E Kellogg; Osheiza Abdulmalik; Martin K Safo
Journal:  J Struct Biol       Date:  2016-04-13       Impact factor: 2.867

4.  Liganded hemoglobin structural perturbations by the allosteric effector L35.

Authors:  Qiuying Chen; Iraj Lalezari; Ronald L Nagel; Rhoda Elison Hirsch
Journal:  Biophys J       Date:  2004-12-30       Impact factor: 4.033

Review 5.  New look at hemoglobin allostery.

Authors:  Yue Yuan; Ming F Tam; Virgil Simplaceanu; Chien Ho
Journal:  Chem Rev       Date:  2015-01-21       Impact factor: 60.622

Review 6.  Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.

Authors:  Martin K Safo; Gregory J Kato
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-21       Impact factor: 3.722

7.  Oxygen-binding heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin.

Authors:  M Zouhair Atassi; Catherine Childress
Journal:  Protein J       Date:  2005-01       Impact factor: 2.371

8.  Extension of the tryptophan chi2,1 dihedral angle-W3 band frequency relationship to a full rotation: correlations and caveats.

Authors:  Laura J Juszczak; Ruel Z B Desamero
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

9.  Structure of fully liganded Hb ζ2β2s trapped in a tense conformation.

Authors:  Martin K Safo; Tzu-Ping Ko; Osheiza Abdulmalik; Zhenning He; Andrew H-J Wang; Eric R Schreiter; J Eric Russell
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-09-20

10.  A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.

Authors:  Akito Nakagawa; Michele Ferrari; Grigorij Schleifer; Marissa K Cooper; Chen Liu; Binglan Yu; Lorenzo Berra; Elizabeth S Klings; Ronni S Safo; Qiukan Chen; Faik N Musayev; Martin K Safo; Osheiza Abdulmalik; Donald B Bloch; Warren M Zapol
Journal:  Mol Pharm       Date:  2018-04-18       Impact factor: 4.939

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.